MNK6106
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MNK6106, covering 2021-07-20 to 2021-07-20. Get the full timeline:
Most recent: Clinical Trial Update: MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) [Phase 2]